These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33927551)

  • 1. Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
    Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
    Biochem Med (Zagreb); 2021 Jun; 31(2):020701. PubMed ID: 33927551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
    Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
    Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-deficient transferrin depends on disease activity in rheumatoid arthritis and systemic sclerosis.
    Gruszewska E; Chludzinska A; Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Szmitkowski M; Sierakowski S
    Scand J Rheumatol; 2013; 42(3):203-6. PubMed ID: 23379548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.
    Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Gruszewska E; Szmitkowski M; Sierakowski S
    Rheumatol Int; 2014 Mar; 34(3):393-9. PubMed ID: 24346772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wongthanee A; Kuwata S; Takeuchi F
    Int J Rheum Dis; 2021 Nov; 24(11):1378-1385. PubMed ID: 34533895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases.
    da Rocha Junior LF; Branco Pinto Duarte AL; de Melo Rêgo MJB; de Almeida AR; de Melo Vilar K; de Lima HD; Tavares Dantas A; de Ataíde Mariz H; da Rocha Pitta I; da Rocha Pitta MG
    Immunol Lett; 2020 Apr; 220():38-43. PubMed ID: 31954799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis.
    Balog JA; Kemeny A; Puskas LG; Burcsar S; Balog A; Szebeni GJ
    Mediators Inflamm; 2021; 2021():5523582. PubMed ID: 34239365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
    Park EH; Strand V; Oh YJ; Song YW; Lee EB
    Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
    Wielosz E; Majdan M; Dryglewska M; Zwolak R
    Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Kuwata S; Takeuchi F
    Clin Rheumatol; 2010 Mar; 29(3):241-6. PubMed ID: 20091076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Power of Galectin-3 in Rheumatic Diseases.
    Gruszewska E; Cylwik B; Gińdzieńska-Sieśkiewicz E; Kowal-Bielecka O; Mroczko B; Chrostek L
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33076422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases.
    Kim MJ; Lee EB; Song YW; Park JK
    Clin Rheumatol; 2020 Oct; 39(10):2899-2906. PubMed ID: 32314175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.
    Stuart RA; Littlewood AJ; Maddison PJ; Hall ND
    Clin Exp Rheumatol; 1995; 13(1):17-22. PubMed ID: 7774098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and hormonal changes between postmenopausal rheumatoid arthritis and systemic lupus erythematosus in women.
    Ali LQ; Abdulhadi FS; El-Haboby BT; Jouda J
    Egypt J Immunol; 2024 Oct; 31(4):76-84. PubMed ID: 39425624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.